11R(12S)-EET
(Synonyms: 11R(12S)-EpETrE,11R(12S)-Epoxy-all-cis-5,8,14-Eicosatrienoic Acid,11R(12S)-Epoxyeicosatrienoic Acid,11R(12S)-Epoxy-5(Z),8(Z),14(Z)-ETrE,FA 20:4;O) 目录号 : GC9150311R(12S)-EET is an oxylipin and a metabolite of arachidonic acid .
Cas No.:123931-38-4
Sample solution is provided at 25 µL, 10mM.
11R(12S)-EET is an oxylipin and a metabolite of arachidonic acid .[1],[2] It is selectively formed from arachidonic acid by the cytochrome P450 (CYP) isoform CYP2C23 and CYP2C24 over CYP2B2, as well as CYP2C8 over CYP2C9. 11R(12S)-EET (50 nM) activates large-conductance calcium-activated potassium channels (KCa1.1/BK) in isolated rat coronary small arterial smooth muscle cells and binds to isolated guinea pig monocytes in a competitive binding assay using [[3]H]14(15)-EET (Ki = 595.1 nM).3,4 It inhibits the epithelial sodium channel (ENaC) in a patch-clamp assay using isolated rat cortical collecting duct tubules when used at a concentration of 100 nM.[5] 11R(12S)-EET induces dilation of precontracted isolated canine epicardial arterioles (EC50 = 6.3 pM) and denuded porcine subepicardial arterioles (EC50 = 1.6 pM).[3] It induces migration of human umbilical vein endothelial cells (HUVECs) when used at a concentration of 5 µM.[6]
References:
[1].Capdevila, J.H., Falck, J.R., and Harris, R.C.Cytochrome P450 and arachidonic acid bioactivation: Molecular and functional properties of the arachidonate monooxygenaseJ. Lipid Res.41(2)163-181(2000).
[2].Daikh, B.E., Lasker, J.M., Raucy, J.L., et al.Regio- and stereoselective epoxidation of arachidonic acid by human cytochromes P450 2C8 and 2C91J. Pharmacol. Exp. Ther.271(3)1427-1433(1994).
[3].Zhang, Y., Oltman, C.L., Lu, T., et al.EET homologs potently dilate coronary microvessels and activate BKCa channelsAm. J. Physiol. Heart Circ. Physiol.280(6)H2430-H2440(2001).
[4].Wong, P.Y.-K., Lai, P.-S., and Falck, J.R.Mechanism and signal transduction of 14 (R), 15 (S)-epoxyeicosatrienoic acid (14,15-EET) binding in guinea pig monocytesProstaglandins Other Lipid Mediat.62(4)321-333(2000).
[5].Sun, P., Lin, D.H., Yue, P., et al.High potassium intake enhances the inhibitory effect of 11,12-EET on ENaCJ. Am. Soc. Nephrol.21(10)1667-1677(2010).
[6].Ding, Y., Frömel, T., Popp, R., et al.The biological actions of 11,12-epoxyeicosatrienoic acid in endothelial cells are specific to the R/S-enantiomer and require the Gs proteinJ. Pharmacol. Exp. Ther.350(1)14-21(2014).
Cas No. | 123931-38-4 | SDF | Download SDF |
别名 | 11R(12S)-EpETrE,11R(12S)-Epoxy-all-cis-5,8,14-Eicosatrienoic Acid,11R(12S)-Epoxyeicosatrienoic Acid,11R(12S)-Epoxy-5(Z),8(Z),14(Z)-ETrE,FA 20:4;O | ||
分子式 | C20H32O3 | 分子量 | 320.5 |
溶解度 | Acetonitrile: Sparingly Soluble: 1-10 mg/ml,Ethanol: Slightly Soluble: 0.1-1 mg/ml | 储存条件 | -20°C |
General tips | 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效。 储备液的保存方式和期限:-80°C 储存时,请在 6 个月内使用,-20°C 储存时,请在 1 个月内使用。 为了提高溶解度,请将管子加热至37℃,然后在超声波浴中震荡一段时间。 |
||
Shipping Condition | 评估样品解决方案:配备蓝冰进行发货。所有其他可用尺寸:配备RT,或根据请求配备蓝冰。 |
制备储备液 | |||
1 mg | 5 mg | 10 mg | |
1 mM | 3.1201 mL | 15.6006 mL | 31.2012 mL |
5 mM | 0.624 mL | 3.1201 mL | 6.2402 mL |
10 mM | 0.312 mL | 1.5601 mL | 3.1201 mL |
第一步:请输入基本实验信息(考虑到实验过程中的损耗,建议多配一只动物的药量) | ||||||||||
给药剂量 | mg/kg | 动物平均体重 | g | 每只动物给药体积 | ul | 动物数量 | 只 | |||
第二步:请输入动物体内配方组成(配方适用于不溶于水的药物;不同批次药物配方比例不同,请联系GLPBIO为您提供正确的澄清溶液配方) | ||||||||||
% DMSO % % Tween 80 % saline | ||||||||||
计算重置 |
计算结果:
工作液浓度: mg/ml;
DMSO母液配制方法: mg 药物溶于 μL DMSO溶液(母液浓度 mg/mL,
体内配方配制方法:取 μL DMSO母液,加入 μL PEG300,混匀澄清后加入μL Tween 80,混匀澄清后加入 μL saline,混匀澄清。
1. 首先保证母液是澄清的;
2.
一定要按照顺序依次将溶剂加入,进行下一步操作之前必须保证上一步操作得到的是澄清的溶液,可采用涡旋、超声或水浴加热等物理方法助溶。
3. 以上所有助溶剂都可在 GlpBio 网站选购。
Quality Control & SDS
- View current batch:
- Purity: >95.00%
- COA (Certificate Of Analysis)
- SDS (Safety Data Sheet)
- Datasheet